Management of MRSA Catheter‑Related Bloodstream Infection in Hemodialysis Patients

Immediate Catheter Management

The 2009 Infectious Diseases Society of America (IDSA) guidelines give a strong recommendation (A‑II) that an infected internal jugular dialysis catheter be removed immediately and a temporary non‑tunneled catheter be placed at a different anatomical site (e.g., contralateral internal jugular or femoral vein) 1.
Guidewire exchange is contraindicated for Staphylococcus aureus CRBSI because it leaves the infected subcutaneous tract in place and is associated with treatment failure 1.

Empiric treatment should include vancomycin for MRSA coverage plus gram‑negative coverage (third‑generation cephalosporin, carbapenem, or β‑lactam/β‑lactamase inhibitor) selected according to the local antibiogram [1][4].
Vancomycin dosing should be administered after each dialysis session to maintain therapeutic levels 4.

A new tunneled hemodialysis catheter should be placed only after blood cultures are documented negative, which typically requires 2–3 days of appropriate antibiotics and confirmed clearance of bacteremia 1.

Standard course: 4–6 weeks when bacteremia persists > 72 hours after catheter removal or when metastatic infection (e.g., endocarditis, septic thrombophlebitis) is suspected [1][4].
Shortened course (10–14 days): permissible if blood cultures become negative within 72 hours, no clinical or imaging evidence of metastatic infection, and the patient is afebrile and clinically stable 4.
Extended course (6–8 weeks): required for documented deep‑seated infections such as osteomyelitis 4.

Obtain surveillance blood cultures 2–3 days after therapy initiation to verify clearance 2.
Actively evaluate for metastatic foci:
- Endocarditis: perform echocardiography if bacteremia persists > 72 hours or a new murmur develops 2.
- Vertebral osteomyelitis, septic arthritis, epidural abscess: assess symptoms (back pain, joint pain, neurologic changes) and inflammatory markers [4][2].

Antibiotic lock therapy is not recommended for S. aureus CRBSI; the IDSA guidelines state that catheter removal is preferred over lock therapy unless no alternative insertion site exists 4.
Catheter salvage attempts for S. aureus have low success (40–55 % cure) and high rates of metastatic complications compared with coagulase‑negative staphylococci (75–84 % cure) 2.

Do not confuse MRSA (S. aureus) with methicillin‑resistant coagulase‑negative staphylococci; the latter may be salvaged with antibiotics and lock therapy, but S. aureus cannot [1][2].
Do not delay catheter removal in hopes that systemic antibiotics alone will eradicate the infection; biofilm formation protects S. aureus and increases the risk of endocarditis and other metastatic infections 1.
Do not place a new catheter at the same site via guidewire exchange, as this leaves the infected tract intact and predisposes to treatment failure 1.